Chrysalis House

Chrysalis House is a SAMHSA-registered addiction-treatment facility in Lexington, KY. The facility's programming is outpatient (Outpatient, Dual Dx), not residential. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at Chrysalis House

On care levels: Chrysalis House is an outpatient-focused program (Outpatient, Dual Dx) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. The critical pre-admission step is an independent clinical assessment that establishes ASAM 4e level-of-care recommendation. Admission at a facility whose offered level does not match the clinical assessment produces most misaligned-placement outcomes.

Insurance and payment

Chrysalis House accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. Before admission, request a written Verification of Benefits from the facility's utilization-review team. Verbal VOB is where most post-admission cost-sharing disputes originate. Written documentation settles them.

Specialty programming

The facility's documented specialty programming includes: Clients with co-occurring mental and substance use disorders, Clients who have experienced intimate partner violence, domestic violence, Clients who have experienced trauma. Evaluating specialty capacity requires asking specifically: what clinicians deliver the specialty content, with what credentials, for how many hours per week. Marketing designation without documented clinical infrastructure is a recognized pattern worth filtering out.

Before you call

The operational due diligence on Chrysalis House comes down to three documents: ASAM-aligned level-of-care documentation matching independent clinical assessment, written Verification of Benefits for your specific plan product, written MAT policy. If the clinical situation involves opioid use disorder, confirm explicitly whether Chrysalis House offers medication-assisted treatment — buprenorphine, methadone, or naltrexone. Programs that do not are operating outside the current standard of care.